Humacyte, Inc. (HUMA) Tops Q2 EPS by 57c

Humacyte, Inc. (NASDAQ: HUMA) reported Q2 EPS of $0.35, $0.57 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $235.4 thousand.

For earnings history and earnings-related data on Humacyte, Inc. (HUMA) click here.

You May Also Be Interested In

• Ferrari CEO says Luce orders "in line with expectations"
• Laureate Education (LAUR) Tops Q2 EPS by 2c; Offers Guidance
• Stagwell Inc (STGW) Tops Q2 EPS by 6c; Offers Guidance